Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies

Author(s): Seyeon Park

Journal Name: Current Pharmacogenomics and Personalized Medicine
Formerly Current Pharmacogenomics

Volume 13 , Issue 1 , 2015

Become EABM
Become Reviewer
Call for Editor


Background: Although clinicians failed to reproduce Pauling and Cameron’s earlier reports on the therapeutic effects of vitamin C on cancer, new information on the pharmacokinetics and pharmacodynamics of vitamin C as well as new clinical data has provided more in depth understanding of the critical aspects of vitamin C’s therapeutic effects. Previous clinical studies suggested that vitamin C, introduced to cancer patients by intravenous and oral pathways, might improve their symptoms. Methods: This review summarizes and focuses on different pharmacological effects of vitamin C that are currently under investigation in pharmacogenomic studies related to transporter gene polymorphism. Conclusion: From the information available, it seems clear that vitamin C is involved in a variety of disease mechanisms. This review might provide an evaluation of vitamin C as a personalized adjuvant medicine.

Keywords: Vitamin C, VitaminC transporter, pharmacogenomics, personalized adjuvant medicine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 14 July, 2015
Page: [3 - 8]
Pages: 6
DOI: 10.2174/1875692113666150714180709

Article Metrics

PDF: 44